Cargando…

Transcriptomic recurrence score improves recurrence prediction for surgically treated patients with intermediate‐risk clear cell kidney cancer

BACKGROUND: Risk stratification of kidney cancer patients after nephrectomy may tailor surveillance intensity and selection for adjuvant therapy. Transcriptomic approaches are effective in predicting recurrence, but whether they add value to clinicopathologic models remains unclear. METHODS: Data fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Neal, Hakansson, Alexander, Ohtake, Shinji, Muraki, Peter, Proudfout, James A., Liu, Yang, Webber, Lisa, Ibarra, Arkaitz, Liu, Vinnie Y. T., Davicioni, Elai, Chamie, Karim, Pantuck, Allan, Shuch, Brian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028022/ https://www.ncbi.nlm.nih.gov/pubmed/36397716 http://dx.doi.org/10.1002/cam4.5399

Ejemplares similares

Understanding the Impact of Belzutifan on Treatment Strategies for Patients with VHL
por: Arevalo, Aileen, et al.
Publicado: (2022)

CD70-Targeted Micelles Enhance HIF2α siRNA Delivery and Inhibit Oncogenic Functions in Patient-Derived Clear Cell Renal Carcinoma Cells
por: Trac, Noah, et al.
Publicado: (2022)

Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinoma
por: Faiena, Izak, et al.
Publicado: (2018)

A lower psoas muscle volume was associated with a higher rate of recurrence in male clear cell renal cell carcinoma
por: Noguchi, Go, et al.
Publicado: (2020)

Discovery and Validation of Novel Expression Signature for Postcystectomy Recurrence in High-Risk Bladder Cancer
por: Mitra, Anirban P., et al.
Publicado: (2014)

Pomegranate extract inhibits EMT in clear cell renal cell carcinoma in a NF-κB and JNK dependent manner
por: An, Jiabin, et al.
Publicado: (2015)

Secondary cytoreductive surgery in recurrent clear cell carcinoma of the endometrium: A case report
por: Cheng, Connie, et al.
Publicado: (2023)

Impact of Decipher on use of post‐operative radiotherapy: Individual patient analysis of two prospective registries
por: Shahait, Mohammed, et al.
Publicado: (2021)

High Recurrence Rate of Myxofibrosarcoma: The Effect of Radiotherapy Is Not Clear
por: Teurneau, Hjalmar, et al.
Publicado: (2019)

Recurrence Quantification of Fractal Structures
por: Webber, Charles L.
Publicado: (2012)

Evolving transcriptomic fingerprint based on genome‐wide data as prognostic tools in prostate cancer
por: Alshalalfa, Mohammed, et al.
Publicado: (2015)

The baseline recurrence risk of patients with intermediate-risk cervical cancer
por: Yoneoka, Yutaka, et al.
Publicado: (2021)

MET Inhibition in Clear Cell Renal Cell Carcinoma
por: Xie, Zuoquan, et al.
Publicado: (2016)

Continuous saline bladder irrigation for two hours following transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer does not prevent recurrence or progression compared with intravesical Mitomycin-C
por: Lenis, Andrew T., et al.
Publicado: (2018)

Radiogenomic profiling of prostate tumors prior to external beam radiotherapy converges on a transcriptomic signature of TGF-β activity driving tumor recurrence
por: Ku, Anson T., et al.
Publicado: (2023)

Analysing the tumor transcriptome of prostate cancer to predict efficacy of Lu-PSMA therapy
por: Handke, Analena, et al.
Publicado: (2023)

Recurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidney
por: Roy, Angshumoy, et al.
Publicado: (2015)

Local recurrence of prostatic ductal adenocarcinoma despite clear surgical margins
por: Merrett, Christopher, et al.
Publicado: (2018)

Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma
por: Lee, Jii Bum, et al.
Publicado: (2019)

Pembrolizumab and lenvatinib in recurrent ovarian clear cell carcinoma resistant to chemotherapy
por: McNamara, Blair, et al.
Publicado: (2023)

Transcriptome-Wide Detection of Differentially Expressed Coding and Non-Coding Transcripts and Their Clinical Significance in Prostate Cancer
por: Erho, Nicholas, et al.
Publicado: (2012)

Business grammar builder: intermediate to upper-intermediate : clear explanations for real situations
por: Emmerson, Paul
Publicado: (2010)

Association between surgical extent and recurrence in unilateral intermediate- to high-risk papillary thyroid cancer
por: Xu, Siyuan, et al.
Publicado: (2023)

Perineural Invasion Should Be Regarded as an Intermediate-Risk Factor for Recurrence in Surgically Treated Cervical Cancer: A Propensity Score Matching Study
por: Wan, Ting, et al.
Publicado: (2021)

Alternate Entropy Computations by Applying Recurrence Matrix Masking
por: Webber, Charles L.
Publicado: (2021)

Recurrence quantification analysis: theory and best practices
por: Webber, Charles, et al.
Publicado: (2015)

Fifth International Symposium on Recurrence Plot
por: Marwan, Norbert, et al.
Publicado: (2014)

Plasma exchange or immunoadsorption for recurrent focal segmental glomerulosclerosis: clear differences in vitro
por: Veissi, Susan T, et al.
Publicado: (2022)

Repurposing Drugs in Controlling Recurrent Platinum-Resistant Clear-Cell Ovarian Cancer
por: Sinsuwan, Woraporn, et al.
Publicado: (2023)

Computational optimum of recurrent neural circuits at intermediate numbers of nonlinear dendritic branches
por: Breuer, David, et al.
Publicado: (2013)

Risk factors for recurrence amongst high intermediate risk patients with endometrioid adenocarcinoma
por: Bahng, Agnes Y., et al.
Publicado: (2012)

AMIGO2 expression as a predictor of recurrence in cervical cancer with intermediate risk
por: Iida, Yuki, et al.
Publicado: (2023)

6th International Symposium on Recurrence Plots
por: Webber, Charles, et al.
Publicado: (2016)

Inferring cancer subnetwork markers using density-constrained biclustering
por: Dao, Phuong, et al.
Publicado: (2010)

Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma
por: Tsai, Harrison K., et al.
Publicado: (2017)

Surgical treatment for recurrent cholangiocarcinoma: a single-center series
por: Fernández, Laura, et al.
Publicado: (2023)

Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trial
por: Tosco, Lorenzo, et al.
Publicado: (2018)

Granulocyte macrophage colony-stimulating factor predicts postoperative recurrence of clear-cell renal cell carcinoma
por: Chang, Yuan, et al.
Publicado: (2016)

Treatment decisions in estrogen receptor-positive early breast cancer patients with intermediate oncotype DX recurrence score results
por: Fried, Georgeta, et al.
Publicado: (2014)

Clinical Validation of the 2005 ISUP Gleason Grading System in a Cohort of Intermediate and High Risk Men Undergoing Radical Prostatectomy
por: Faraj, Sheila F., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hstp77nq3m7okfrf5tbf22emst